NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Lisa Biopeptide? Mail in a sample (US only) and let us test it.

Test my supply
+9 more ↓
67%
Finnrick rating
#245 of 345 ranked vendors
47 of 67 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Lisa Biopeptide's Purity focus record is product-specific, with Tesamorelin and GHK-Cu carrying the cleaner recent identity/purity evidence. Retatrutide and Tirzepatide show severe identity/quantity outliers, while BPC-157 has repeated purity misses; thin batch IDs make consistency harder to judge.

methodology →
vendor intelligence report
Vendor Intelligence Report: Lisa Biopeptide

Corporate-record checks, domain history, and backdated site articles point to a young China-linked storefront rather than a verified manufacturer. The dossier maps the 35.com account, Telegram/WhatsApp rails, payment-recourse issues, and Lisa-brand impersonation exposure.

23 pages7 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
84%
11
2
Retatrutide
$0.85
71%
30
3
Tirzepatide
$0.47
70%
14
4
Tesamorelin
$1.50
60%
6
5
BPC-157
$0.69
45%
6
7
AOD-9604
$1.40
-
0
10
hCG
-
-
0
12
MOTS-c
-
-
0
13
NAD+
$0.02
-
0
14
PT-141
$0.65
-
0
16
SS-31
$0.60
-
0
17
TB-500
$1.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%6 Mar 2026: 65%6 Mar 2026: 65%10 Mar 2026: 66%18 Mar 2026: 67%18 Mar 2026: 67%18 Mar 2026: 68%18 Mar 2026: 68%18 Mar 2026: 68%18 Mar 2026: 69%19 Mar 2026: 69%21 Apr 2026: 69%23 Apr 2026: 69%23 Apr 2026: 69%23 Apr 2026: 68%23 Apr 2026: 67%23 Apr 2026: 68%23 Apr 2026: 68%27 Apr 2026: 68%28 Apr 2026: 68%28 Apr 2026: 69%28 Apr 2026: 69%6 May 2026: 70%6 May 2026: 70%4 Jun 2026: 71%4 Jun 2026: 71%8 Jun 2026: 70%8 Jun 2026: 69%1 Jul 2026: 70%1 Jul 2026: 71%1 Jul 2026: 71%21 Jul 2026: 70%22 Jul 2026: 70%22 Jul 2026: 70%22 Jul 2026: 70%3 Aug 2026: 69%4 Aug 2026: 69%5 Aug 2026: 68%21 Aug 2026: 68%21 Aug 2026: 68%26 Aug 2026: 68%21 Sept 2026: current 67%65%71%67%Mar 26Sep 26
Free peptide testing

Ordered peptides from Lisa Biopeptide? Mail in a sample (US only) and let us test it.

Test my supply
Lisa Biopeptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
26 Aug 2026
Fail
GHK-Cu
lab nameView COA
21 Aug 2026
Pass
Tirzepatide
lab nameView COA
21 Aug 2026
Pass
Retatrutide
lab nameView COA
5 Aug 2026
Fail
Retatrutide
lab nameView COA
4 Aug 2026
Fail
Retatrutide
lab nameView COA
3 Aug 2026
Fail
Tirzepatide
lab nameView COA
22 Jul 2026
Pass
GHK-Cu
lab nameView COA
22 Jul 2026
Pass
Tirzepatide
lab nameView COA
22 Jul 2026
Fail
BPC-157
lab nameView COA
21 Jul 2026
Fail
Tirzepatide
lab nameView COA
1-10 of 67

About Lisa Biopeptide test results from Finnrick

Lisa Biopeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 67 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Lisa Biopeptide peptides in this dataset are BPC-157 (6 tests), GHK-Cu (11 tests) and Retatrutide (30 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 67 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Lisa Biopeptide? Mail in a sample (US only) and let us test it.

Test my supply